Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2018-01-24 2018-01-24
Drug Identification Number 02455447 02455447
Brand name INVOKAMET INVOKAMET
Common or Proper name canagliflozin and metformin hydrochloride tablets canagliflozin and metformin hydrochloride tablets
Company Name JANSSEN INC JANSSEN INC
Ingredients METFORMIN HYDROCHLORIDE Canagliflozin METFORMIN HYDROCHLORIDE Canagliflozin
Strength(s) 850MG 150MG 850MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1x60 1x60
ATC code A10BD A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-05-08 2018-05-08
Actual discontinuation date
Remaining supply date 2018-05-08 2018-05-08
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments